Data / Form D filings / Kanvas Biosciences, Inc.
Kanvas Biosciences, Inc.: Form D filings
Kanvas Biosciences, Inc., a health care company in Monmouth Junction, NJ, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on March 18, 2024, reports $3.9 million sold of a $10 million offering to 54 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 DEER PARK DRIVE, SUITE G-5, Monmouth Junction, NJ, 08852
- Phone
- (617) 435-4900
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1980849
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | New notice | $10,000,000 | $3,914,994 | $6,085,006 | 54 | Mar 4, 2024 | sec.gov |
| Jun 13, 2023 | New notice | $12,000,000 | $11,775,000 | $225,000 | 12 | Jun 1, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Theunissen | Director | |
| Jason Pontin | Director | |
| Matthew Cheng | Executive Officer, Director | |
| Hao Shi | Executive Officer, Director |
Other health care companies in New Jersey that filed recently
- SURGICAL CENTER OF SOUTH JERSEY LP $280,125 · Oct 8, 2026
- Morris County Surgical Center, LLC $140,380 · Sep 28, 2026
- Acuitive Technologies, Inc. $1.9 million · Sep 24, 2026
- Meca Industries Corp $37,500 · Sep 21, 2026
- ZT Technology PE 1, LLC offering · Sep 9, 2026
- OLI Technologies, Inc. offering · Sep 4, 2026
Every Form D from the week of Mar 18, 2024 · All recent filings in New Jersey · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Kanvas Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.